238 related articles for article (PubMed ID: 6593266)
1. [Results of treatment with 2 chemotherapeutic protocols (TAPA and VAPA) in acute myeloblastic leukemia].
Avilés-Miranda A; Ambriz-Fernández R; García-Vela E; Monroy-Arellano L; Pizzuto J
Gac Med Mex; 1984 Apr; 120(4):145-50. PubMed ID: 6593266
[No Abstract] [Full Text] [Related]
2. [Possibilities for the cure of acute myeloblastic leukemia with the modified VAPA regimen: preliminary results].
Díaz Mediavilla J; del Potro Gómez E; Llorente Pérez L; Martínez Martínez R; Guerra Moyano JL; de la Vega Bueno E; Alvarez Carmona A; Krsnik Castelló I; Alarcón Zurita C; Rodríguez Vázquez M
Med Clin (Barc); 1984 Dec; 83(19):783-6. PubMed ID: 6597329
[No Abstract] [Full Text] [Related]
3. [Treatment of acute myeloid leukemia].
Obrecht JP
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(2):190-200. PubMed ID: 6208102
[No Abstract] [Full Text] [Related]
4. [Therapy of acute myeloblastic leukemia. Thoughts after preliminary results].
Weinfeld A; Ridell B; Westin J
Nord Med; 1970 Dec; 84(49):1574. PubMed ID: 5275102
[No Abstract] [Full Text] [Related]
5. [Comparative analysis of 3 therapeutic regimens based on the combination of an anthracycline and cytosine arabinoside for remission induction in myeloblastic leukemia].
Sanz MA; Lorenzo JI; Sanz GF; Martín Aragonés G; Rafecas FJ; Martínez JA; Gomis F
Sangre (Barc); 1988 Dec; 33(6):497-504. PubMed ID: 3247626
[No Abstract] [Full Text] [Related]
6. [Late results of the treatment of acute granulocytic leukemia in adults].
Perilov AA; Volkova MA; Frenkel' MA
Ter Arkh; 1989; 61(7):8-11. PubMed ID: 2588148
[TBL] [Abstract][Full Text] [Related]
7. Neutrophilic eccrine hidradenitis in acute myelomonocytic leukemia.
Katsanis E; Luke KH; Hsu E; Carpenter BF; Mantynen PR
Am J Pediatr Hematol Oncol; 1987; 9(3):204-8. PubMed ID: 3479026
[TBL] [Abstract][Full Text] [Related]
8. [Acute refractory lymphoblastic leukemia in the adult. Treatment with daunorubicin, cytosine arabinoside, 6-thioguanine, vincristine and prednisone].
Marín P; Grañena A; Carreras E; Ribera JM; Rozman C
Sangre (Barc); 1984; 29(6):987-92. PubMed ID: 6598237
[No Abstract] [Full Text] [Related]
9. [Results of combined treatment of advanced forms of multiple myeloma with vincristine, melphalan, cyclophosphamide and prednisone (VMCP) and with vincristine, doxorubicin, cyclophosphamide and prednisone (VDCP)].
Robak T; Krykowski E; Płuzańska A; Olszańska-Skorek T; Urbańska-Ryś H; Polkowska-Kulesza E; Błasińska-Morawiec M; Mazurowa A
Pol Tyg Lek; 1983 Apr; 38(16):481-4. PubMed ID: 6579509
[No Abstract] [Full Text] [Related]
10. [Acute lymphoblastic leukemia in adults: results of the DATOP-79 protocol].
Ribera JM; Grañena A; Sierra J; Urbano-Ispizua A; Brugués R; Rozman C
Med Clin (Barc); 1988 Nov; 91(17):653-7. PubMed ID: 3230971
[No Abstract] [Full Text] [Related]
11. [Treatment of acute leukemias].
Gross R; Gerecke D
Wien Klin Wochenschr; 1982 Nov; 94(21):591-6. PubMed ID: 6963072
[TBL] [Abstract][Full Text] [Related]
12. Early acute myeloblastic leukemia treatment for childhood myelodysplastic syndrome with t(3;5) (NPM/MLF1).
Sevilla J; Fernández-Plaza S; Lassaletta A; González-Vicent M; Contra T; Madero L
J Pediatr Hematol Oncol; 2007 Dec; 29(12):839-40. PubMed ID: 18090933
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of acute myelogenous leukemia in adults; an account of the years 1968 to 1975].
Willemze R; den Ottolander GJ; Heering KJ; Brand A; Zwaan FE; Haak HL; Hartgrink-Groeneveld CA; Jansen J; Eernisse JG
Ned Tijdschr Geneeskd; 1977 Nov; 121(46):1843-7. PubMed ID: 270615
[No Abstract] [Full Text] [Related]
14. [Intensive polychemotherapy in the treatment of acute non-lymphoblastic leukemia: comparison of the prospective protocols DATOP/79 and DATOP/82].
Carreras E; Grañena A; Sierra J; Marín P; Rozman C
Med Clin (Barc); 1987 Feb; 88(6):223-7. PubMed ID: 3561058
[No Abstract] [Full Text] [Related]
15. Comparative observations in the treatment of acute leukaemia.
Gráf F; Fekete S; Benedek S; Sréter L; Takácsi-Nagy L
Haematologia (Budap); 1976; 10(1):81-7. PubMed ID: 1070470
[TBL] [Abstract][Full Text] [Related]
16. Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group.
Nickenig C; Dreyling M; Hoster E; Pfreundschuh M; Trumper L; Reiser M; Wandt H; Lengfelder E; Unterhalt M; Hiddemann W;
Cancer; 2006 Sep; 107(5):1014-22. PubMed ID: 16878325
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy of the non-Hodgkin's lymphomas: the Stanford experience.
Portlock CS; Rosenberg SA
Cancer Treat Rep; 1977 Sep; 61(6):1049-55. PubMed ID: 332344
[No Abstract] [Full Text] [Related]
18. Development of a curative treatment within the AML-BFM studies.
Creutzig U; Zimmermann M; Dworzak MN; Ritter J; Schellong G; Reinhardt D
Klin Padiatr; 2013 May; 225 Suppl 1():S79-86. PubMed ID: 23700063
[TBL] [Abstract][Full Text] [Related]
19. [HOAP/HOAGP in the treatment of acute non-lymphocytic leukemia: an analysis of 68 cases].
Shan YD
Zhonghua Yi Xue Za Zhi; 1985 Oct; 65(10):590-2. PubMed ID: 3938671
[No Abstract] [Full Text] [Related]
20. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
